For someone diagnosed with uveal melanoma, you may hear your healthcare team discuss the possibility of metastasis and the importance of monitoring the liver. Understanding what these terms mean can make follow-up conversations easier to navigate.

What does “metastatic” mean?

Metastasis occurs when cancer cells spread from the part of the body where the cancer originally developed to another part of the body.

When uveal melanoma spreads elsewhere, it is called metastatic uveal melanoma. For example, if uveal melanoma cells spread to the liver, the cancer remains uveal melanoma—it does not become liver cancer. (Cancer.gov)

Where can uveal melanoma spread?

Uveal melanoma can spread to different parts of the body. Because of the biology and anatomy of the eye, the cancer typically spreads through the bloodstream rather than through the lymphatic system.

The liver is the most common site where metastatic uveal melanoma is identified. Other sites can include the lungs, bones, and other tissues. (Cancer.gov)

Why is the liver an important focus?

Because of the strong association between metastatic uveal melanoma and the liver, healthcare teams may pay particular attention to liver health during follow-up.

Monitoring may involve imaging, laboratory testing, or other evaluations depending on an individual’s medical history and risk factors.

The appropriate approach is not the same for everyone. Your healthcare team can explain what type of monitoring is recommended for you and why.

Why does surveillance and follow-up matter?

Uveal melanoma may not cause obvious symptoms if it spreads. Ongoing follow-up gives healthcare teams an opportunity to monitor for changes over time and evaluate findings in the context of each patient’s individual risk.

Keeping scheduled appointments and discussing any new symptoms with your healthcare team are important parts of ongoing care.

Who may be involved in ongoing care?

Because uveal melanoma begins in the eye but can affect other parts of the body, patients may encounter several different healthcare specialists.

The specialists involved may change over time based on an individual’s needs.

Where can I learn more?

Reliable educational information about uveal melanoma and metastatic disease is available through organizations including the National Cancer Institute and American Cancer Society, as well as patient advocacy organizations focused on ocular melanoma.

If you have questions about metastatic risk or liver surveillance, bring them to your healthcare team. They can help explain how general information about uveal melanoma relates to your individual diagnosis.

Stay Connected

Follow Delcath for more patient education, company updates and perspectives from the oncology community.